Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors

US8604055B2 · kind B2 · utility

Assignee

• DR. REDDY'S LABORATORIES LIMITED · IN

Inventors

• Anima Baruah · Hyderabad, IN
• Dibyendu De · Suwanee, US
• Ish Khanna · Vernon Hills, US
• Sivaram Pillarisetti · Norcross, US
• Santanu Maitra · Hyderabad, IN
• Christopher W. Alexander · Norcross, US
• Jennepalli Sreenu · Darsi, IN
• Indu Dagar · Sidhauli, IN
• Shanavas Alikunju · Darsi, IN

Key dates

• Filing date: Jun 28, 2006
• Grant date: Dec 10, 2013
• Expiry date: Apr 3, 2031

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D498/04
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

The present invention provides, among other things, new benzylamine compounds, compositions comprising benzylamine compounds, methods of making benzylamine compounds, and methods of using benzylamine compounds for treating or preventing a variety of conditions or diseases associated with lipoprotein metabolism.